Meilleure Health International Industry Group Limited (2327) Stock Statistics & Valuation Metrics

Meilleure Health International Industry Group Limited has a market cap or net worth of HK$1.19B. The enterprise value is HK$1.54B.

Meilleure Health International Industry Group Limited has 4,093,756,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Meilleure Health International Industry Group Limited’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is -0.43%.

The current PE Ratio of Meilleure Health International Industry Group Limited is 28.5. Meilleure Health International Industry Group Limited’s PEG ratio is 1.61.

In the last 12 months, Meilleure Health International Industry Group Limited had revenue of 36.52M and earned 37.98M in profits. Earnings per share was <0.01.

In the last 12 months, operating cash flow was -50.02M and capital expenditures -583.00K, giving a free cash flow of -50.60M billion.

Meilleure Health International Industry Group Limited pays an annual dividend of HK$0.002, resulting in a dividend yield of 2%

Meilleure Health International Industry Group Limited upcoming earnings date is Aug 27, 2026, TBA (Confirmed).

Meilleure Health International Industry Group Limited as a current ratio of 2.81, with Debt / Equity ratio of 30.51%

In the past 12 months, Meilleure Health International Industry Group Limited has paid 7.46M in taxes.

Meilleure Health International Industry Group Limited EV to EBITDA ratio is -160.81, with an EV/FCF ratio of -28.52.

Meilleure Health International Industry Group Limited has HK$20.18M in cash and marketable securities with HK$380.96M in debt, giving a net cash position of -HK$360.77M billion.

Gross margin is 61.97%, with operating margin of -26.59%, and net profit margin of 104.01%.

The average price target for Meilleure Health International Industry Group Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―